Aspect Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Aspect Partners's AMGN Position: Q3 2026 in Review
Aspect Partners reduced its Amgen (AMGN) stake by 0.3% in Q3 2026, selling an estimated $399 and leaving 332 shares worth $140K. The position accounts for 0.05% of the portfolio, ranked #96.
Aspect Partners first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $276K in Q2 2025. 1,006 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Aspect Partners held 332 shares of Amgen worth $140K as of Q3 2026.
- Aspect Partners sold 1 Amgen share in Q3 2026, an estimated $399.
- Amgen made up 0.05% of Aspect Partners's portfolio in Q3 2026, its #96 holding.
- Aspect Partners first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
- Aspect Partners's Amgen position peaked at $276K in Q2 2025.
- 1,006 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.